Viewing Study NCT04772235


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2025-12-31 @ 8:19 PM
Study NCT ID: NCT04772235
Status: RECRUITING
Last Update Posted: 2024-04-03
First Post: 2021-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
Sponsor: Instituto Oncológico Dr Rosell
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module